Clearside Biomedical, Inc.
CLSD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $70,113 | $72,314 | $67,429 | $160,853 |
| - Cash | $20,020 | $28,920 | $48,258 | $30,436 |
| + Debt | $52,470 | $43,001 | $35,262 | $675 |
| Enterprise Value | $102,563 | $86,395 | $54,433 | $131,092 |
| Revenue | $1,664 | $8,226 | $1,327 | $29,575 |
| % Growth | -79.8% | 519.9% | -95.5% | – |
| Gross Profit | $1,515 | $7,871 | $1,123 | $29,575 |
| % Margin | 91% | 95.7% | 84.6% | 100% |
| EBITDA | -$24,347 | -$23,058 | -$29,463 | $554 |
| % Margin | -1,463.2% | -280.3% | -2,220.3% | 1.9% |
| Net Income | -$34,352 | -$32,485 | -$32,947 | $376 |
| % Margin | -2,064.4% | -394.9% | -2,482.8% | 1.3% |
| EPS Diluted | -7.05 | -7.95 | -8.25 | 0.095 |
| % Growth | 11.3% | 3.6% | -8,830.2% | – |
| Operating Cash Flow | -$24,698 | -$18,135 | -$13,365 | -$10,733 |
| Capital Expenditures | -$977 | -$1,777 | -$246 | $0 |
| Free Cash Flow | -$25,675 | -$19,912 | -$13,611 | -$10,733 |